CAS NO: | 724711-21-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | MK2-IN-3 is a potent and selective inhibitor ofMAPKAP-K2 (MK-2), with anIC50of 8.5 nM. MK2-IN-3 shows selectivity for MK-2 over MK-3, MK-5,ERK2,MNK1, p38a (IC50s=0.21, 0.081, 3.44, 5.7, and >100 μM, respectively) and MSK1, MSK2,CDK2,JNK2, IKK2 (IC50s>200 μM). MK2-IN-3 can reduce TNFα production in both U937 cells and in vivo[1]. | ||||||||||||||||
IC50& Target | IC50: 8.5 nM (MK-2); 81 nM (MK-5); 210 nM (MK-3); 3.44 μM (ERK2); 5.7 μM (MNK1)[1] | ||||||||||||||||
体外研究 (In Vitro) | MK2-IN-3 (compound 16) inhibits MK-2 and TNFα production in U937 cells, with IC50s of 8.5 nM and 4.4 μM, respectively[1]. | ||||||||||||||||
体内研究 (In Vivo) | MK2-IN-3 (compound 16) (20 mg/kg; a single p.o. before LPS challenge) inhibits 20% TNFα production in rat LPS (rLPS) model[1]. | ||||||||||||||||
分子量 | 340.38 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H16N4O | ||||||||||||||||
CAS 号 | 724711-21-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 62.5 mg/mL(183.62 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |